Featured
Key factors for combining MIGS
A review of the rationale and outcomes of combining multiple microinvasive glaucoma surgeries
By Won I. Kim, MD
Laser treatment vs drops
Data-driven recommendation patterns are emerging for a growing range of options.
By Kristin O. Chapman, MD
Diagnosing glaucoma: COVID-19 and beyond
The pandemic has changed glaucoma care, but traditional tools still have their place.
By Cheryl N. Zimmer, OD
Glaucoma plus OSD equals double trouble
Corneal irritation, lid and orbital changes may be due to drops — but these patients often have distinct co-existing ocular surface disease as well.
By Conni Koury, contributing writer
Augmenting glaucoma care with supplements
Promising research on nutritional supplements offers an adjunctive for standard glaucoma management.
By Natasha Nayak Kolomeyer, MD
Lessening the drop load in cataract surgery
These methods will reduce eyedrop burden, save staff time and improve compliance for your postop patient.
By Cynthia Matossian MD, FACS
News
Quick Hits
How to prepare for Provider Relief Fund audits
By Kathy Hargreaves, CPA, CFP, CPC, Sam Phillips, CPA
Departments
Enhancing Practice Performance
It’s time to make rounds
By Corinne Z. Wohl, MHSA, COE, John B. Pinto
BEST PRACTICES
Financial leadership: More than numbers
By Andrew Maller, MBA, COE, LAURA BALDWIN, CPC, ELI-MP, RN
RX PERSPECTIVE
A natural treatment for dry eye
SPOTLIGHT ON TECHNOLOGY & TECHNIQUE
A new standard of care — no strings attached
By Joseph F. Jalkiewicz, contributing writer
INDUSTRY INSIDER
Aviceda Therapeutics’ Mohamad Genead, MD
Transforming the glaucoma treatment paradigm
Sustained-release drug delivery may make non-compliance a thing of the past.
Web Exclusives
New cancer drug requires an ophthalmic assist
Blenrep has been released under a REMS program to fight myeloma.
By RENE LUTHE